Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol and dexamethasone for prevention of Hemabate-induced gastrointestinal adverse reactions during cesarean delivery
ChiCTR-IPR-14005749Phase 4Recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of droperidol, dexamethasone and carboprost in Nausea and Vomiting (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: nausea and vomiting, pulse and 1 more. Started Dec 2014; status: recruiting.
02
Drugs
droperidoldexamethasonecarboprost
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on ChiCTR-IPR-14005749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005749.